A detailed history of Saturna Capital Corp transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Saturna Capital Corp holds 9,779 shares of CRSP stock, worth $452,669. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,779
Previous 9,779 -0.0%
Holding current value
$452,669
Previous $528,000 13.07%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$51.17 - $68.18 $58,896 - $78,475
-1,151 Reduced 10.53%
9,779 $528,000
Q4 2023

Feb 06, 2024

BUY
$38.62 - $72.18 $422,116 - $788,927
10,930 New
10,930 $684,000
Q2 2023

Aug 04, 2023

BUY
$43.47 - $67.77 $162,273 - $252,985
3,733 New
3,733 $209,000
Q4 2021

Feb 09, 2022

SELL
$70.09 - $111.29 $131,769 - $209,225
-1,880 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$110.2 - $156.64 $11,020 - $15,663
100 Added 5.62%
1,880 $210,000
Q2 2021

Aug 11, 2021

BUY
$100.84 - $161.89 $179,495 - $288,164
1,780 New
1,780 $288,000
Q1 2021

May 14, 2021

SELL
$110.72 - $210.04 $1.44 Million - $2.73 Million
-13,000 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$79.67 - $173.23 $95,604 - $207,876
-1,200 Reduced 8.45%
13,000 $1.99 Million
Q2 2020

Aug 14, 2020

BUY
$38.5 - $76.05 $546,700 - $1.08 Million
14,200 New
14,200 $1.04 Million
Q1 2020

May 14, 2020

SELL
$33.68 - $62.53 $114,512 - $212,602
-3,400 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$36.68 - $73.13 $124,712 - $248,641
3,400 New
3,400 $207,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.